Soleus Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Soleus Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$2.72M	–	107
2025 Q3	$2.72M	Sell	100,000 -150,000	-60%	-$3.63M	0.14%	68
2025 Q2	$5.25M	Buy	+250,000	New	+$4.8M	0.35%	52
2024 Q4	–	Sell	-1,049,314	Closed	-$33.2M	–	94
2024 Q3	$33.2M	Buy	1,049,314 +355,245	+51%	+$13.5M	2.57%	12
2024 Q2	$24.4M	Buy	694,069 +160,554	+30%	+$6.36M	2.15%	11
2024 Q1	$23.4M	Sell	533,515 -31,185	-6%	-$1.34M	1.74%	16
2023 Q4	$20.1M	Buy	+564,700	New	+$16.9M	2.23%	17

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Soleus Capital Management's IDYA Position: Q4 2025 in Review

Soleus Capital Management sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 100,000 shares — an estimated $2.72M sold.

Soleus Capital Management first reported a position in IDYA in Q4 2023 and held it in 6 quarters. The position peaked at $33.2M in Q3 2024. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

Soleus Capital Management reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
Soleus Capital Management sold 100,000 IDEAYA Biosciences shares in Q4 2025, an estimated $2.72M.
Soleus Capital Management first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 6 quarters.
Soleus Capital Management's IDEAYA Biosciences position peaked at $33.2M in Q3 2024.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Soleus Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.